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Abstract
Background: The retroperitoneal margin is frequently microscopically tumour positive in non-curative periampullary
adenocarcinoma resections. This margin should be evaluated by serial perpendicular sectioning. The aim of the study was to
determine whether retroperitoneal margin involvement independently predicts survival after pancreaticoduodenectomy within
a framework of standardized assessment of the resected specimens.
Methods: 114 consecutive macroscopically margin-free periampullary adenocarcinomas were examined according to a
prospective standardized protocol for histopathologic evaluation. The retroperitoneal margin was assessed by serial
perpendicular sectioning. The periampullary cancer origin (pancreas, ampulla, distal bile duct or duodenum) was registered
prospectively and reevaluated retrospectively. Associations between histopathologic factors were evaluated by Chi-square test,
Fisher's exact test, Kruskal-Wallis test, and Mann-Whitney test, as appropriate. Survival curves were calculated by the Kaplan-
Meier method and compared using the log-rank test. Associations between histopathologic factors and survival were also
evaluated by unadjusted and adjusted Cox regression analysis, including stepwise variable selection, in order to identify factors
that independently predict a poor prognosis after periampullary adenocarcinoma resections.
Results: Microscopic resection margin involvement (R1 resection) was present in 40 tumours, of which 32 involved the
retroperitoneal margin. Involvement of the retroperitoneal margin independently predicted a poor prognosis (p = 0.010; HR
1.89; CI 1.16–3.08) after presumed curative (R0 and R1) resection. In microscopically curative (R0) resections (n = 74),
pancreatic tumour origin was the only factor that independently predicted a poor prognosis (p < 0.001; HR 4.71 for pancreatic
versus ampullary; CI 2.13–10.4).
Conclusion: Serial perpendicular sectioning of the retroperitoneal resection margin demonstrates that tumour involvement of
this margin independently predicts survival after pancreaticoduodenectomy for adenocarcinoma. Periampullary tumour origin is
the only histopathologic factor that independently predicts survival in microscopically curative (R0) resections.
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Resectable primary adenocarcinomas located in the pan-
creatic head may derive from the pancreatic tissue, the
hepatopancreatic ampulla, the distal bile duct or the duo-
denum, and collectively these cancers may be referred to
as periampullary adenocarcinomas [1]. The precise
tumour origin is often impossible to determine prior to
surgery, and pancreaticoduodenectomy is thus performed
for all four types irrespective of tumour origin. Complete
tumour removal is one of the most important factors
influencing long-term survival after resection [2-6]. How-
ever, even after margin-free resection (R0 resection) the
recurrence rate is high and the majority of patients suc-
cumb to the disease within 5 years [2-6].
The reported proportion of patients having tumour
involved resection margins (R1 resection) after pancreati-
coduodenectomy varies considerably, in the range
31–85% for pancreatic tumours and 2–27% for ampul-
lary tumours [1,2,7-10]. The large variation may partly be
explained by underreporting of R1 resections due to non-
standardized protocols for microscopic evaluation of the
resection margins [9,11]. Furthermore, little is known
about the relative importance of the different resection
margins in R1 resections as determinants for survival
[5,9,12]. The techniques employed for examination of the
resected specimens clearly influence the reported rates of
R0/R1 resections. Several groups have suggested guide-
lines for standardization of histopathologic assessment
[13-19]. However, the retroperitoneal resection margin,
which is most often involved in non-curative resections
[5,13,20,21], is often not systematically evaluated in stud-
ies reporting histopathologic prognostic factors after pan-
creaticoduodenectomy [22-25].
The considerable variations in reported percentages of R1
resections for pancreatic and ampullary tumours may also
be explained by difficulties in determining the cancer ori-
gin. Even after systematic histopathologic evaluation, the
precise origin may be impossible to determine due to
tumour destruction of normal periampullary anatomy
[13,26-29]. There is also considerable normal variation of
periampullary ductal structures, adding to the difficulties
[26]. The common practice of reporting data on only a
single periampullary subtype makes comparison of stud-
ies difficult due to the expected variations in inclusion and
exclusion criteria for periampullary subtypes. For exam-
ple, survival after resection of ductal pancreatic adenocar-
cinoma may be overestimated if ampullary cases are not
adequately excluded [30]. Adjusted Cox regression analy-
sis [31] including tumour origin as a covariate adjusts for
some of the uncertainties regarding periampullary sub-
type classification, and also eliminates redundant or
duplicate information resulting from associations
between tumour origin and other covariates. Thus, we
propose that survival analysis of all periampullary adeno-
carcinomas should include the tumour origin as a covari-
ate rather than only presenting the results from separate
subgroups.
Starting from 1998, we have employed a standardized
protocol for evaluation of pancreaticoduodenectomy
specimens, including serial perpendicular sectioning of
the retroperitoneal resection margin and prospective eval-
uation of the cancer origin. The aim of this study was to
investigate whether tumour involvement of the retroperi-
toneal margin is an independent prognostic factor for sur-
vival after resection of periampullary adenocarcinoma.
Tumour origin was included as a covariate both in the
overall adjusted analysis of all presumed curative (R1 and
R0) periampullary resections and in a separate subgroup
analysis of R0 resections.
Methods
Patient cohort
The study was approved by the National Committees for
Research Ethics in Norway, project number S-05081, and
was in compliance with the Helsinki Declaration. From
1998 to 2004, 161 consecutive patients underwent pan-
creaticoduodenectomy at the Department of Surgery, Rik-
shospitalet University Hospital, a third-level referral
hospital. Of these, 114 patients (55 women and 59 men;
median age 68 years; range 41–82) had primary adenocar-
cinoma with macroscopically free margins (R0 or R1
resections). Seventy six of the 114 included patients died
before the end of the study, and the remaining 38 patients
were followed up for a median of 4.8 years (range
1.6–8.4). None of the patients received preoperative
chemo- or radiotherapy. During the study period,
national guidelines did not recommend postoperative
chemo- or radiotherapy. All patients underwent a stand-
ard Whipple's procedure including a distal gastrectomy.
An effort was made to skeletonize the superior mesenteric
and portal veins and the superior mesenteric artery in all
cases, without performing extended lymphadenectomy.
There were three cases with vascular resection (of which
one tumour originated in the peripapillary duodenum
and two were pancreatic). Intra-operative frozen sections
from the bile duct and pancreatic neck resection margins
were performed upon macroscopic suspicion of tumour
involvement. Perioperative death (in-hospital death or
death within 30 days of operation) was 3.5% (4/114).
Cases with perioperative death were included in the sur-
vival analysis.
Standardized protocol for examination of resection 
specimens
In this study, we defined the retroperitoneal margin as the
area of sharp dissection in the peripancreatic fatty tissue
behind the pancreatic head and lateral to the mesentericPage 2 of 10
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denectomy specimen in formalin, one block from the
pancreatic neck and distal bile duct resection margins,
respectively, was secured. These sections were taken paral-
lel to the resection margins (shave sections). One block
from the stomach and small bowel resection margins,
respectively, was also secured. The retroperitoneal margin
was identified and inked, and a section parallel to the
resection margin (5–10 mm thick slice) was made, from
which serial perpendicular sectioning into 5 mm thick
slices was performed (Figure 2) [11,13]. The pancreatic
duct and the distal bile duct, and their orifice(s) at the
duodenal surface were identified, and probes were
inserted in order to locate any obstruction within these
ducts. A section parallel to the ductal structures, including
duodenum, ampulla, distal bile duct and pancreatic
parenchyma on a single slide, was made in order to dem-
onstrate the tumour's relation to each of these potential
sites of origin (Figure 3) [1]. Cross sections into the
tumour were then made to evaluate tumour size and
potential infiltration into adjacent structures. Lymph
nodes were sampled from the duodenal knee and large
and lesser curvatures of the stomach.
Histopathologic evaluation of specimens
The following histopathologic factors were prospectively
registered by routine examination: Tumour origin, maxi-
mum tumour diameter, degree of differentiation,
perineural infiltration, vascular infiltration, dysplasia or
other tumour associated pathologic changes, lymph node
status, and resection margin status (pancreatic, bile duct,
stomach, jejunal and retroperitoneal margins evaluated
independently). All registrations were later reevaluated by
an experienced pathologist. Finally, tumour origin was
independently assessed by a second experienced patholo-
gist. The cancer origin was determined by assessing
tumour location relative to ductal anatomy and duodenal
and pancreatic parenchyma, and by noting any associated
epithelial dysplasia or in situ neoplasia. Upon disagree-
ment, consensus was reached by discussion. All tumours
were assigned to one of the four types using this approach.
The final allocation of tumour origin corresponded with
the initial prospective evaluation in 89 of 114 specimens
(78%).
An R0 resection was defined as both macro- and micro-
scopically free margins. An R1 resection was defined as
tumour within 1 mm of a resection margin upon micro-
scopic examination of haematoxylin and eosin stained
sections. An R2 resection was defined as macroscopic
residual tumour at the operative site, as described in the
surgeon's operative report. Degree of differentiation was
classified according to a two-score system as proposed by
Lüttges et al. [32], distinguishing high-grade from low-
grade carcinomas by presence or no presence, respectively,
of areas with poorly differentiated tumour.
Statistical analysis
Survival data were obtained from the National Registry of
Norway. The Kaplan-Meier method was used to calculate
curves for overall survival and to estimate median sur-
vival. Survival curves were compared using the log-rank 
Close-up of the posterior aspect of a pancreaticoduodenec-tomy specimen fr m a patient with adenocarcin ma in th  pancreati  head without tumour in iltrati n in o the retro-eritoneal argin, before (A) and after (B) fixati n in fo ma-linFigu e 1
Close-up of the posterior aspect of a pancreaticoduodenec-
tomy specimen from a patient with adenocarcinoma in the 
pancreatic head without tumour infiltration into the retro-
peritoneal margin, before (A) and after (B) fixation in forma-
lin. The retroperitoneal resection margin was defined as the 
area of sharp dissection (white stapled area) in the peripan-
creatic fatty tissue behind the pancreatic head and lateral to 
the mesenteric vessels. In this case this area was relatively 
small. In cases with tumour infiltration or inflammation 
involving the posterior aspect of the pancreatic head, the size 
of this sharply dissected area may extend into the superior 
mesenteric vein groove (A, indicated by the forceps) or to a 
larger part of the posterior pancreatic surface (B, red stapled 
area). The black stapled area (A, B) indicates the pancreatic 
neck transection margin.Page 3 of 10
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Whole-mount section parallel to the ampulla, distal bile duct 
and pancreatic duct, demonstrating periampullary tumour 
growth relative to ductal anatomy, for determination of the 
site of cancer origin. (A) White areas on the macroscopic 
photograph indicate possible tumour growth. (B) On micro-
scopic examination, this tumour was found to originate from 
the peri-papillary duodenum (du), although it also involved 
the entire ampullary region (stapled area), and the distal por-
tions of the distal bile duct (bd) and pancreatic duct (pd). In 
such cases, and in particular if epithelial dysplasia or in situ 
neoplasia also affects more than one periampullary subloca-
tion, determination of the cancer origin may be difficult, and 
virtually impossible without systematic histopathologic exam-
ination.
(A) Posterior view of a pancreaticoduodenectomy specimen with periampullary adenocarcinoma infiltrating the retrop ri-toneal resection margiFigur  2
(A) Posterior view of a pancreaticoduodenectomy specimen 
with periampullary adenocarcinoma infiltrating the retroperi-
toneal resection margin. The specimen includes the pyloric 
part of the stomach (st), the duodenum (du), adipose tissue 
which is part of the greater omentum, and the head and unc-
inate process of pancreas. The retroperitoneal resection 
margin was identified and marked with ink. (B) A section par-
allel to this resection margin was made. (C) Perpendicular 
sections of the retroperitoneal resection margin demon-
strate pancreatic parenchyma and connective tissue, includ-
ing fat, vessels and nerves, with infiltration of tumour cells < 
1 mm from the inked margin (visible on higher magnification), 
thus revealing a non-curative (R1) resection.Page 4 of 10
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examined using Chi-square test and Fisher's exact test.
Mann-Whitney test and Kruskal-Wallis test were per-
formed to compare tumour diameter (measured as a con-
tinuous variable) between groups of independent
samples. The factors evaluated were: tumour origin, max-
imum tumour diameter, degree of differentiation,
perineural infiltration, vascular infiltration, lymph node
status, and resection margin status (pancreatic, bile duct,
and retroperitoneal margins; no tumour infiltrated the
stomach or jejunal resection margins).
Cox regression models were fitted in order to estimate
unadjusted and adjusted survival after presumed curative
(R0 and R1) resection, together with the hazard ratios
with their 95% confidence intervals. For categorical varia-
bles, the group with the best prognosis in unadjusted
analysis was set as reference. Hazards were proportional
for all covariates, allowing inclusion of covariates in the
adjusted analysis without need for stratification. All the
examined histopathologic factors were significant in the
unadjusted analysis and were thus included in the
adjusted models. Two separate models were fitted for
adjusted analysis of all histopathologic factors, consider-
ing the resection margins collectively (R1 versus R0) and
individually (retroperitoneal margin free versus involved,
and pancreatic margin free versus involved; omitting the
stomach and duodenal resection margins, that had no
cases with tumour involvement, and the distal bile duct
margin, that had only two cases with tumour involve-
ment). Factors were evaluated using forward stepwise var-
iable selection, thus avoiding inclusion of variables with
redundant prognostic information. In order to estimate
the relative importance of the individual resection mar-
gins, the adjusted analysis was repeated after exclusion of
the seven patients that had multiple margin tumour
involvement. This analysis gave very similar results, with
the same covariates in the final adjusted models as in the
analysis including all 114 patients. These seven patients
were thus not excluded from the analysis. A separate
adjusted Cox regression subgroup analysis was performed
for R0 resected patients in order to determine the factors
that were independently associated with survival in cura-
tive resections. The proportional hazards assumption was
evaluated by examination of log minus log plots (see
Additional file 1: Verification of the proportional hazards
assumption). Likelihood ratio test was computed to
examine possible interactions between covariates (see
Additional file 2: Evaluation of possible interaction
between tumour origin and resection margin status).
All statistical analyses were performed with SPSS 15.0 for
Windows software (SPSS Inc., Chicago, Illinois, USA). A
two-sided p < 0.05 was considered statistically significant.
Results
In this study of 114 macroscopically margin-free pancrea-
ticoduodenectomies, 65% and 35% were R0 and R1 resec-
tions, respectively (Table 1). The retroperitoneal margin
was involved by tumour infiltration in 80% of the R1
resections (32 of 40). Seven of the thirty-two tumours that
infiltrated the retroperitoneal margin also infiltrated the
pancreatic neck transection margin (of which two also
infiltrated the distal bile duct margin). Resection margin
involvement was significantly associated with each of the
other prognostically poor histopathologic factors
(regional lymph node involvement, p < 0.001; vessel infil-
tration, p = 0.001; perineural infiltration, p < 0.001; pres-
ence of areas with poor differentiation, p = 0.005; large
tumour, p = 0.013). Resection margin involvement was
most frequent when the tumour originated from the distal
bile duct or pancreas (p = 0.009).
Unadjusted overall survival
In the unadjusted Cox regression analysis of 114 periam-
pullary adenocarcinomas, tumour involvement of the
resection margins predicted a poor prognosis compared to
margin-free resections (Figure 4; see also Additional file 3:
Unadjusted analysis of histopathologic prognostic fac-
tors), both when the resection margins were modelled
collectively (R1 versus R0 resections, p < 0.001) and sepa-
rately (retroperitoneal margin involved versus free, p <
0.001; pancreatic neck transection margin involved versus
free, p = 0.003; bile duct resection margin involved versus
free, p = 0.005). As expected, patients with cancer originat-
ing from the pancreas had the worst prognosis, with a
median postoperative survival of 1.2 years (95% CI:
1.0–1.4), compared to 4.9 years (95% CI: 2.4–7.4) for
ampullary tumours (p < 0.001). However, although the
prognosis for R0 resected patients was significantly associ-
ated with tumour origin (p < 0.001), the prognosis after
non-complete (R1) resections did not depend on tumour
origin (p = 0.45). Comparing resections of pancreatic and
ampullary tumours (Figure 5), resection status was found
to be a more powerful predictor for survival for patients
with ampullary tumour (p < 0.001, Figure 5B) than for
patients with pancreatic tumour (p = 0.30, Figure 5A).
Patients with ductal pancreatic adenocarcinoma had an
estimated, statistically non-significant survival benefit of
only five months for curative versus non-curative resec-
tion (p = 0.30, Figure 5A), while most of the patients with
R0 resected ampullary tumours were still alive by the end
of the study (19 of 31; median survival not reached, >5
years) and all patients with R1 resected ampullary
tumours were dead by the end of the study (10 of 10) (p
< 0.001, Figure 5B). The interaction between resection
margin status and tumour origin for these two groups was
statistically significant (p = 0.009).Page 5 of 10
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In order to establish whether the retroperitoneal resection
margin was an independent prognostic factor for clini-
cally resectable periampullary adenocarcinomas (R0 and
R1 resections), we performed adjusted Cox regression
analysis including in a forward variable selection process
all the variables that were significant in the unadjusted
analysis. This resulted in the adjusted models (Table 2), in
which tumour involvement of one or more resection mar-
gins (Table 2A), and the retroperitoneal margin in partic-
ular (Table 2B), independently predicted a poor prognosis
after pancreaticoduodenectomy for periampullary adeno-
carcinoma (p = 0.010), adjusting for lymph node status
and perineural infiltration (p < 0.01 for each, in both
adjusted models).
Survival after microscopically margin-free resections
Finally, we performed a subgroup analysis of all patients
that underwent a curative (R0) resection (n = 74). Pancre-
atic tumour origin was significantly associated with each
of the other prognostically poor histopathologic factors
(regional lymph node involvement, p = 0.008; vessel infil-
tration, p = 0.004; perineural infiltration, p < 0.001; pres-
ence of areas with poor differentiation, p = 0.001; large
tumour, p < 0.001). Although these factors were signifi-
cantly associated with survival in unadjusted analysis,
adjusted analysis with stepwise forward variable selection
resulted in a final model that included only tumour ori-
gin, which was thus the only independent predictor of
survival after curative pancreaticoduodenectomy in the
present study. The hazard ratio for R0 resected ductal pan-
creatic versus ampullary adenocarcinoma was 4.71 (95%
CI: 2.13–10.4, p < 0.001). Median survival for patients
with R0 resected pancreatic cancer was 1.3 years (95% CI:
1.0–1.6) while patients with R0 resected non-pancreatic
cancer survived median more than 5 years (median sur-
vival not reached for ampullary and duodenal cases; p <
0.001).
Discussion
Standardized protocols for evaluation of the resection
margins should be mandatory in studies reporting prog-
nostic data on periampullary adenocarcinomas
[1,9,13,19,33]. The retroperitoneal margin should be
evaluated by serial perpendicular sectioning [13]. Insuffi-
cient examination of the retroperitoneal margin might
lead to underreporting of R1 resections[9,11]. Although
most investigators report overall resection margin
involvement to be an independent prognostic factor
[2,3,7,8,34], some investigators have concluded other
Table 1: Origin of tumour versus margin involvement and other histopathologic characteristics in 114 periampullary 
adenocarcinomas
Origin of tumour Total
(n = 114)
p-valuea
Ampulla
(n = 41)
Duodenum
(n = 16)
Distal bile duct
(n = 17)
Pancreas
(n = 40)
Margin involvement 0.009b
Any margin (R1 resections) 10 2 10 18 40
Retroperitoneal 9 1 8 14 32
Pancreatic neck 2 1 5 7 15
Distal bile duct 0 0 0 2 2
No margin (R0 resections) 31 14 7 22 74
Other histopathologic characteristics
Nodal status 0.005
N1 17 10 7 31 65
N0 24 6 10 9 49
Degree of differentiation 0.009
Poor 8 5 9 21 43
High or moderate 33 11 8 19 71
Vessel involvement 0.013
yes 9 4 9 21 43
no 32 12 8 19 71
Perineural infiltration <0.001
yes 13 6 11 32 62
no 28 10 6 8 52
Tumour size <0.001c
large (diameter ≥ 2.6 cm) 8 11 6 23 48
small (diameter ≤ 2.5 cm) 33 5 11 17 66
aChi-square test, when not otherwise specified
bR1 vs R0 resection
cMeasured as a continuous variable, Kruskal-Wallis test and Mann-Whitney test (pancreatic vs non-pancreatic)Page 6 of 10
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Overall survival for R0 versus R1 resection of tumours originating in (A) the pancreas (n = 40; p = 0.30) and (B) the ampulla (n 
= 41; p < 0.001).
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Overall survival after pancreaticoduodenectomy for periampullary adenocarcinoma (n = 114) with (A) free versus involved ret-
roperitoneal resection margin (p < 0.001) and (B) R0 versus R1 resection (p < 0.001).
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were not included in these reports. In the present study we
have used a standardized systematic protocol for his-
topathologic assessment of resection margin involve-
ment, with special attention to the retroperitoneal
margin. Our main finding was that resection margin
involvement, and retroperitoneal margin involvement in
particular, independently predicts a poor prognosis in
curative-intent (R0 and R1) resections for periampullary
adenocarcinoma. In addition, we found that the anatomic
tumour origin was the only independent prognostic factor
in macro- and microscopic margin-free (R0) resections.
A problem when considering standardization of his-
topathologic reporting of pancreaticoduodenectomy
specimens is that the definition of the retroperitoneal
resection margin varies considerably. Some investigators
define this margin simply as "the peripancreatic fat tissue
behind the head of the pancreas [13,15]." Others include
only the tissue directly adjacent to the proximal 3–4 cm of
the superior mesenteric artery [16,19], sometimes with a
clear distinction between the "retroperitoneal" and the
"posterior pancreatic" resection margins [16]. The retro-
peritoneal margin is also often synonymously referred to
as the "posterior," "mesenteric" or "uncinate" margin
[14,17]. Some have advocated examination of the whole
peripancreatic fatty tissue resection margin [20,21,35].
Verbeke et al. [9] recently evaluated a standardized proto-
col for examination of the circumferential resection mar-
gin, subdividing this margin into the anterior, posterior
and superior mesenteric vein groove circumferential resec-
tion margins. In cases with inflammation and tumour
invasion it may be difficult to distinguish between such
distinct resection margins. Most important for evaluation
of tumour margin infiltration is the area of sharp dissec-
tion, the extent of which varies depending on the degree
of inflammation and tumour invasion. In our study, we
thus widened the strictest definition of the retroperitoneal
resection margin, but omitted separate analysis of each
aspect of the circumferential peripancreatic margin in
order to avoid extensive sampling.
The use of non-standardized protocols for histopatho-
logic assessment may not only cause inconsistencies in
the reporting of R0 versus R1 rates, but could also lead to
differences with respect to classification of the anatomic
site of tumour origin [1,13]. In the present study, tumour
origin did not independently predict survival in presumed
curative (R0 and R1) resections, although this factor was
borderline significant when evaluated in a base model
adjusting for all other histopathologic factors. There are
probably two reasons for this. First, patients with pancre-
atic tumours (with the poorest prognosis in unadjusted
analysis) frequently had resection margin involvement
(45%). Thus, adjusting for resection margin status in the
adjusted analysis renders tumour origin statistically non-
significant. Second, in the unadjusted analysis, tumour
origin was significantly associated with survival only in
R0, not R1, resections. Consequently, in the adjusted anal-
ysis for R0 resected patients, tumour origin was the only
histopathologic factor that independently predicted long-
term survival after pancreaticoduodenectomy.
Interestingly, patients with ampullary adenocarcinoma
had a considerable survival benefit of a retroperitoneal
margin-free resection, while a free margin at this site was
only non-significantly associated with survival for
patients who had adenocarcinoma originating in the pan-
creas. Even when considering the resection margins col-
lectively, we found only a non-significant tendency
towards some five months benefit of having a margin-free
resection in the pancreatic group. This is in line with pre-
vious reports, since the difference between median sur-
vival of patients with margin-free versus margin-involved
resections from ductal pancreatic adenocarcinoma has
typically been reported to be about half a year [5,8,9,36-
38]. In a large, multicenter, prospective study of resected
pancreatic cancer, Neoptolemos et al. [36] found that
resection margin status was not an independent predictor
of survival in ductal pancreatic adenocarcinoma. The ret-
roperitoneal resection margin was however not systemat-
ically evaluated, and the R0 rate was exceptionally high
(81%), possibly underestimating the rate of R1 resections
[9]. In a study primarily comparing pancreaticoduodenec-
tomy with or without vascular resection, Tseng et al. [37]
reported that retroperitoneal margin involvement was not
an independent prognostic factor in patients with pancre-
atic adenocarcinoma. However, stepwise variable selec-
tion was not performed, and the definition of the
retroperitoneal margin was restricted to the area directly
adjacent to the superior mesenteric artery. Evaluating
individual resection margins in 160 resected pancreatic
adenocarcinomas, Kuhlmann et al. [5] found that R0
resection independently predicted a favourable prognosis,
Table 2: Adjusted Cox regression analysis of histopathologic 
prognostic factors (n = 114)
HR 95% CI p-value
A. Model 1
Resection margin status R1 (vs R0) 1.90 1.17–3.10 0.010
Lymph nodes N1 (vs N0) 2.24 1.28–3.91 0.005
Perineural infiltration yes (vs no) 2.22 1.31–3.75 0.003
B. Model 2
Retroperitoneal margin involved 
(vs free)
1.89 1.16–3.08 0.010
Lymph nodes N1 (vs N0) 2.29 1.32–3.99 0.003
Perineural infiltration yes (vs no) 2.32 1.38–3.92 0.002
HR, hazard ratio. HR > 1 indicates increased probability of death 
compared to the reference groupPage 8 of 10
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BMC Cancer 2008, 8:5 http://www.biomedcentral.com/1471-2407/8/5but did not report the independent prognostic impor-
tance for survival of the retroperitoneal margin in particu-
lar. Thus, to establish whether or not involvement of the
retroperitoneal resection margin independently predicts
the prognosis also in ductal pancreatic adenocarcinoma,
larger studies using standardized evaluation of both
tumour origin and the individual resection margins
should be performed.
Conclusion
Systematic histopathologic evaluation confirms that
resection margin involvement, and retroperitoneal mar-
gin involvement in particular, independently predicts a
poor prognosis in curative-intent (R0 and R1) resections
of periampullary adenocarcinoma. Involvement of the
retroperitoneal margin is frequent in pancreatic, distal
bile duct and ampullary tumours, and serial perpendicu-
lar sectioning of the retroperitoneal margin should thus
be performed in all pancreatic head adenocarcinomas to
avoid underestimation of R1 resections.
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